Michael J. Dickinson, Leanne Berkahn, Judith Trotman, Jason Butler, Mathias Bressel, Paul Neeson et al. Pembrolizumab as first therapy for elderly or comorbid patients with classical Hodgkin lymphoma: Results of the phase 2 PLIMATH trial. // British Journal of Haematology. – 2026. – DOI: 10.1111/bjh.70777. – URL: https://onlinelibrary.wiley.com/doi/10.1111/bjh.70777?af=R
Michael J. Dickinson, Leanne Berkahn, Judith Trotman, Jason Butler, Mathias Bressel, Paul Neeson, & Adrian G. Minson (2026). Pembrolizumab as first therapy for elderly or comorbid patients with classical Hodgkin lymphoma: Results of the phase 2 PLIMATH trial. British Journal of Haematology. https://doi.org/10.1111/bjh.70777
Michael J. Dickinson, et al. “Pembrolizumab as first therapy for elderly or comorbid patients with classical Hodgkin lymphoma: Results of the phase 2 PLIMATH trial.” British Journal of Haematology, 2026. doi:10.1111/bjh.70777.
@article{Dickinson2026,
title = {Pembrolizumab as first therapy for elderly or comorbid patients with classical Hodgkin lymphoma: Results of the phase 2 PLIMATH trial},
author = {Dickinson, Michael J. and Berkahn, Leanne and Trotman, Judith and Butler, Jason and Bressel, Mathias and Neeson, Paul and Minson, Adrian G.},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70777},
url = {https://onlinelibrary.wiley.com/doi/10.1111/bjh.70777?af=R}
}